Yan Wang, a prominent inventor based in Foster City, CA, has made significant strides in the field of biopharmaceuticals with an impressive portfolio of 13 patents. Her work focuses on developing binding agents that play a crucial role in immunotherapy and targeted treatments.

Latest Patents

Two of her latest patents include groundbreaking innovations in binding agents:

1. **LAIR-1-binding agents and methods of use thereof**: This patent provides insights into binding agents, including antibodies, that specifically bind to LAIR-1, particularly human LAIR-1. The disclosure encompasses related compositions, methods of use, polynucleotides, vectors encoding these binding agents, and the cells that carry them.

2. **ILT3-binding agents and methods of use thereof**: Similar to her previous work, this patent outlines antibodies that target ILT3, including human ILT3. It details compositions comprising these binding agents, methods for their use, along with related polynucleotides and encoding vectors.

Career Highlights

Yan Wang is currently employed at Ngm Biopharmaceuticals, Inc., where her innovative research contributes to the development of novel therapeutic solutions. Her expertise and dedication to advancing biopharmaceuticals have positioned her as a valuable asset to her team and the industry as a whole.

Collaborations

At Ngm Biopharmaceuticals, Yan collaborates with talented individuals like Zhonghao Liu and Hugo Matern. These collaborations enhance the research environment, fostering mutual growth and the advancement of innovative projects.

Conclusion

Yan Wang’s extensive patent portfolio and collaborative efforts in the field of biopharmaceuticals exemplify her commitment to innovation and scientific advancement. Her work not only holds promise for future therapies but also highlights the impact inventors like her can have on the medical landscape.

This text is generated by artificial intelligence and may not be accurate.